These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33810315)

  • 1. Non-Alcoholic Fatty Liver Disease Is an Independent Risk Factor for LDL Cholesterol Target Level.
    Lee JH; Lee HS; Cho AR; Lee YJ; Kwon YJ
    Int J Environ Res Public Health; 2021 Mar; 18(7):. PubMed ID: 33810315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased levels of low-density lipoprotein cholesterol within the normal range as a risk factor for nonalcoholic fatty liver disease.
    Sun DQ; Liu WY; Wu SJ; Zhu GQ; Braddock M; Zhang DC; Shi KQ; Song D; Zheng MH
    Oncotarget; 2016 Feb; 7(5):5728-37. PubMed ID: 26735337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of low-density lipoprotein cholesterol within the normal range and NAFLD in the non-obese Chinese population: a cross-sectional and longitudinal study.
    Sun DQ; Wu SJ; Liu WY; Wang LR; Chen YR; Zhang DC; Braddock M; Shi KQ; Song D; Zheng MH
    BMJ Open; 2016 Dec; 6(12):e013781. PubMed ID: 27927668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LDL/HDL cholesterol ratio is associated with new-onset NAFLD in Chinese non-obese people with normal lipids: a 5-year longitudinal cohort study.
    Zou Y; Zhong L; Hu C; Zhong M; Peng N; Sheng G
    Lipids Health Dis; 2021 Mar; 20(1):28. PubMed ID: 33766067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-high-density lipoprotein cholesterol independently predicts new onset of non-alcoholic fatty liver disease.
    Zelber-Sagi S; Salomone F; Yeshua H; Lotan R; Webb M; Halpern Z; Santo E; Oren R; Shibolet O
    Liver Int; 2014 Jul; 34(6):e128-35. PubMed ID: 24118857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-alcoholic fatty liver disease (NAFLD) and 10-year risk of cardiovascular diseases.
    Motamed N; Rabiee B; Poustchi H; Dehestani B; Hemasi GR; Khonsari MR; Maadi M; Saeedian FS; Zamani F
    Clin Res Hepatol Gastroenterol; 2017 Feb; 41(1):31-38. PubMed ID: 27597641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: An 8-year follow-up study.
    Lu ZY; Shao Z; Li YL; Wulasihan M; Chen XH
    World J Gastroenterol; 2016 Apr; 22(13):3663-9. PubMed ID: 27053858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Risk for Cardiovascular Events in Patients with Diabetic Kidney Disease and Non-Alcoholic Fatty Liver Disease.
    Chinnadurai R; Chrysochou C; Kalra PA
    Nephron; 2019; 141(1):24-30. PubMed ID: 30384370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.
    Ampuero J; Ranchal I; Gallego-Durán R; Pareja MJ; Del Campo JA; Pastor-Ramírez H; Rico MC; Picón R; Pastor L; García-Monzón C; Andrade R; Romero-Gómez M
    J Gastroenterol Hepatol; 2016 Sep; 31(9):1611-8. PubMed ID: 26946071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Study of Serum Homocysteine and Non-Alcoholic Fatty Liver Disease in Euglycemic Patients.
    Hu Y; Liu J; Dong X; Xu Y; Leng S; Wang G
    Med Sci Monit; 2016 Nov; 22():4146-4151. PubMed ID: 27803497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonoverweight nonalcoholic fatty liver disease and incident cardiovascular disease: A post hoc analysis of a cohort study.
    Yoshitaka H; Hamaguchi M; Kojima T; Fukuda T; Ohbora A; Fukui M
    Medicine (Baltimore); 2017 May; 96(18):e6712. PubMed ID: 28471965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults.
    Alexander M; Loomis AK; van der Lei J; Duarte-Salles T; Prieto-Alhambra D; Ansell D; Pasqua A; Lapi F; Rijnbeek P; Mosseveld M; Avillach P; Egger P; Dhalwani NN; Kendrick S; Celis-Morales C; Waterworth DM; Alazawi W; Sattar N
    BMJ; 2019 Oct; 367():l5367. PubMed ID: 31594780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of gamma-glutamyl transferase as a suitable simple biomarker of the cardiovascular risk in children with non-alcoholic fatty liver disease.
    Bobrus-Chociej A; Flisiak-Jackiewicz M; Daniluk U; Wojtkowska M; Kłusek-Oksiuta M; Tarasów E; Lebensztejn D
    Acta Biochim Pol; 2018 Oct; 65(4):539-544. PubMed ID: 30380561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty liver index and development of cardiovascular disease in Koreans without pre-existing myocardial infarction and ischemic stroke: a large population-based study.
    Kim JH; Moon JS; Byun SJ; Lee JH; Kang DR; Sung KC; Kim JY; Huh JH
    Cardiovasc Diabetol; 2020 May; 19(1):51. PubMed ID: 32359355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease.
    Chinnadurai R; Ritchie J; Green D; Kalra PA
    Nephrol Dial Transplant; 2019 Mar; 34(3):449-457. PubMed ID: 29390103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total cholesterol to high-density lipoprotein cholesterol ratio is a significant predictor of nonalcoholic fatty liver: Jinchang cohort study.
    Ren XY; Shi D; Ding J; Cheng ZY; Li HY; Li JS; Pu HQ; Yang AM; He CL; Zhang JP; Ma YB; Zhang YW; Zheng TZ; Bai YN; Cheng N
    Lipids Health Dis; 2019 Feb; 18(1):47. PubMed ID: 30744645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of apolipoprotein B dyslipoproteinemias in non-alcoholic fatty liver disease: The lifelines cohort study.
    Nass KJ; van den Berg EH; Faber KN; Schreuder TCMA; Blokzijl H; Dullaart RPF
    Metabolism; 2017 Jul; 72():37-46. PubMed ID: 28641782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular risk factors in non-alcoholic fatty liver disease.
    Hagström H; Nasr P; Ekstedt M; Hammar U; Stål P; Askling J; Hultcrantz R; Kechagias S
    Liver Int; 2019 Jan; 39(1):197-204. PubMed ID: 30253056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of nonalcoholic fatty liver disease with cardiovascular risk factors in obese adolescents: the role of interdisciplinary therapy.
    Sanches PL; de Piano A; Campos RM; Carnier J; de Mello MT; Elias N; Fonseca FA; Masquio DC; da Silva PL; Corgosinho FC; Tock L; Oyama LM; Tufik S; Dâmaso AR
    J Clin Lipidol; 2014; 8(3):265-72. PubMed ID: 24793347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-alcoholic Fatty Liver Disease Is Associated With Aortic Calcification: A Cohort Study With Propensity Score Matching.
    Zhu RR; Gao XP; Liao MQ; Cui YF; Tan SX; Zeng FF; Lou YM; Wang CY; Xu S; Peng XL; Dai SH; Zhao D; Wang L; Ping Z; Dai XY; Feng PN; Han LY
    Front Endocrinol (Lausanne); 2022; 13():880683. PubMed ID: 35651978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.